Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma

Completed · Phase 2

Conditions studied: Lymphoma

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy consisting of liposomal doxorubicin, cyclophosphamide, vincristine, and prednisone in treating patients with AIDS-related lymphoma.

Key facts

Study ID

NCT00003388

Run by

Eastern Cooperative Oncology Group

People needed

38

Starts

1999-07-26

Last updated by the study team

2023-06-22

Who can join

Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Veterans Affairs Medical Center - Palo Alto — Palo Alto, California, United States
• Stanford University Medical Center — Stanford, California, United States
• Raritan Bay Medical Center — Perth Amboy, New Jersey, United States
• Albert Einstein Comprehensive Cancer Center — The Bronx, New York, United States
• MBCCOP-Our Lady of Mercy Cancer Center — The Bronx, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.